Foresite Capital Management Iv, LLC Alector, Inc. Transaction History

Foresite Capital Management Iv, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$16.25 - $35.28 $5.74 Million - $12.5 Million	-353,462 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$14.17 - $20.3 $8.26 Million - $11.8 Million	-582,909 Reduced 62.25%	353,462 $6.09 Million
Q3 2019 Nov 13, 2019	SELL	$14.42 - $22.2 $2.99 Million - $4.6 Million	-207,091 Reduced 18.11%	936,371 $13.5 Million
Q2 2019 Aug 13, 2019	SELL	$16.26 - $26.42 $975,600 - $1.59 Million	-60,000 Reduced 4.99%	1,143,462 $21.7 Million
Q1 2019 May 14, 2019	BUY	$15.97 - $22.5 $19.2 Million - $27.1 Million	1,203,462 New	1,203,462 $10.7 Million

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $156M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.